 | • レポートコード：QYR9N8209 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、女性の健康治療薬のグローバル市場について調査・分析したレポートで、種類別（感染、妊娠、腫瘍学）、用途別（20歳未満、20〜50歳、> 50歳）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・女性の健康治療薬の世界市場規模 ・主要企業別市場シェア ・女性の健康治療薬の世界市場規模：種類別（感染、妊娠、腫瘍学） ・女性の健康治療薬の世界市場規模：用途別（20歳未満、20〜50歳、> 50歳） ・女性の健康治療薬のアメリカ市場規模（種類別、用途別） ・女性の健康治療薬のヨーロッパ市場規模（種類別、用途別） ・女性の健康治療薬の中国市場規模（種類別、用途別） ・女性の健康治療薬の日本市場規模（種類別、用途別） ・女性の健康治療薬の東南アジア市場規模（種類別、用途別） ・女性の健康治療薬のインド市場規模（種類別、用途別） ・女性の健康治療薬の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・女性の健康治療薬の世界市場予測（2019年-2025年） ・女性の健康治療薬の地域別市場予測（2019年-2025年） ... |
Women’s health in dermatology covers a vast array of topics that range from issues surrounding management of skin disease during pregnancy and lactation, available hormonal therapies for conditions such as acne and alopecia, hormonally driven conditions that are linked to dermatologic skin diseases such as polycystic, etc.Growing awareness regarding cancer, menopause, osteoporosis, and infections is expected to drive the market for women’s health therapeutics. Moreover, introduction of new drug therapies by major market players is likely to contribute to market expansion in the forthcoming years.
Continuous rise in prevalence of chronic and lifestyle-associated disorders in women is likely to propel market growth. In addition, growing healthcare investment for early detection of cancer and infectious diseases, complications related to pregnancy, and launch of new and effective drugs are likely to further drive the market.
In 2018, the global Women’s Health Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Women’s Health Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Women’s Health Therapeutics development in United States, Europe and China.
The key players covered in this study
Bayer AG
Pfizer, Inc.
Teva Pharmaceutical
F. Hoffmann-La Roche Ltd.
Merck & Co., Inc.
Bristol-Myers Squibb Company
AstraZeneca
Novartis AG
Eli Lilly and Company
GlaxoSmithKline plc
Mylan N.V.
Sanofi
Sun Pharmaceutical Industries Ltd.
CooperSurgical, Inc.
Market segment by Type, the product can be split into
Infection
Pregnancy
Oncology
Market segment by Application, split into
<20 Years Old
20~50 Years Old
>50 Years Old
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Women’s Health Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Women’s Health Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Women’s Health Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Women’s Health Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Infection
1.4.3 Pregnancy
1.4.4 Oncology
1.5 Market by Application
1.5.1 Global Women’s Health Therapeutics Market Share by Application (2014-2025)
1.5.2 <20 Years Old
1.5.3 20~50 Years Old
1.5.4 >50 Years Old
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Women’s Health Therapeutics Market Size
2.2 Women’s Health Therapeutics Growth Trends by Regions
2.2.1 Women’s Health Therapeutics Market Size by Regions (2014-2025)
2.2.2 Women’s Health Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Women’s Health Therapeutics Market Size by Manufacturers
3.1.1 Global Women’s Health Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Women’s Health Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Women’s Health Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Women’s Health Therapeutics Key Players Head office and Area Served
3.3 Key Players Women’s Health Therapeutics Product/Solution/Service
3.4 Date of Enter into Women’s Health Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Women’s Health Therapeutics Market Size by Type (2014-2019)
4.2 Global Women’s Health Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Women’s Health Therapeutics Market Size (2014-2019)
5.2 Women’s Health Therapeutics Key Players in United States
5.3 United States Women’s Health Therapeutics Market Size by Type
5.4 United States Women’s Health Therapeutics Market Size by Application
6 Europe
6.1 Europe Women’s Health Therapeutics Market Size (2014-2019)
6.2 Women’s Health Therapeutics Key Players in Europe
6.3 Europe Women’s Health Therapeutics Market Size by Type
6.4 Europe Women’s Health Therapeutics Market Size by Application
7 China
7.1 China Women’s Health Therapeutics Market Size (2014-2019)
7.2 Women’s Health Therapeutics Key Players in China
7.3 China Women’s Health Therapeutics Market Size by Type
7.4 China Women’s Health Therapeutics Market Size by Application
8 Japan
8.1 Japan Women’s Health Therapeutics Market Size (2014-2019)
8.2 Women’s Health Therapeutics Key Players in Japan
8.3 Japan Women’s Health Therapeutics Market Size by Type
8.4 Japan Women’s Health Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Women’s Health Therapeutics Market Size (2014-2019)
9.2 Women’s Health Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Women’s Health Therapeutics Market Size by Type
9.4 Southeast Asia Women’s Health Therapeutics Market Size by Application
10 India
10.1 India Women’s Health Therapeutics Market Size (2014-2019)
10.2 Women’s Health Therapeutics Key Players in India
10.3 India Women’s Health Therapeutics Market Size by Type
10.4 India Women’s Health Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Women’s Health Therapeutics Market Size (2014-2019)
11.2 Women’s Health Therapeutics Key Players in Central & South America
11.3 Central & South America Women’s Health Therapeutics Market Size by Type
11.4 Central & South America Women’s Health Therapeutics Market Size by Application
12 International Players Profiles
12.1 Bayer AG
12.1.1 Bayer AG Company Details
12.1.2 Company Description and Business Overview
12.1.3 Women’s Health Therapeutics Introduction
12.1.4 Bayer AG Revenue in Women’s Health Therapeutics Business (2014-2019)
12.1.5 Bayer AG Recent Development
12.2 Pfizer, Inc.
12.2.1 Pfizer, Inc. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Women’s Health Therapeutics Introduction
12.2.4 Pfizer, Inc. Revenue in Women’s Health Therapeutics Business (2014-2019)
12.2.5 Pfizer, Inc. Recent Development
12.3 Teva Pharmaceutical
12.3.1 Teva Pharmaceutical Company Details
12.3.2 Company Description and Business Overview
12.3.3 Women’s Health Therapeutics Introduction
12.3.4 Teva Pharmaceutical Revenue in Women’s Health Therapeutics Business (2014-2019)
12.3.5 Teva Pharmaceutical Recent Development
12.4 F. Hoffmann-La Roche Ltd.
12.4.1 F. Hoffmann-La Roche Ltd. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Women’s Health Therapeutics Introduction
12.4.4 F. Hoffmann-La Roche Ltd. Revenue in Women’s Health Therapeutics Business (2014-2019)
12.4.5 F. Hoffmann-La Roche Ltd. Recent Development
12.5 Merck & Co., Inc.
12.5.1 Merck & Co., Inc. Company Details
12.5.2 Company Description and Business Overview
12.5.3 Women’s Health Therapeutics Introduction
12.5.4 Merck & Co., Inc. Revenue in Women’s Health Therapeutics Business (2014-2019)
12.5.5 Merck & Co., Inc. Recent Development
12.6 Bristol-Myers Squibb Company
12.6.1 Bristol-Myers Squibb Company Company Details
12.6.2 Company Description and Business Overview
12.6.3 Women’s Health Therapeutics Introduction
12.6.4 Bristol-Myers Squibb Company Revenue in Women’s Health Therapeutics Business (2014-2019)
12.6.5 Bristol-Myers Squibb Company Recent Development
12.7 AstraZeneca
12.7.1 AstraZeneca Company Details
12.7.2 Company Description and Business Overview
12.7.3 Women’s Health Therapeutics Introduction
12.7.4 AstraZeneca Revenue in Women’s Health Therapeutics Business (2014-2019)
12.7.5 AstraZeneca Recent Development
12.8 Novartis AG
12.8.1 Novartis AG Company Details
12.8.2 Company Description and Business Overview
12.8.3 Women’s Health Therapeutics Introduction
12.8.4 Novartis AG Revenue in Women’s Health Therapeutics Business (2014-2019)
12.8.5 Novartis AG Recent Development
12.9 Eli Lilly and Company
12.9.1 Eli Lilly and Company Company Details
12.9.2 Company Description and Business Overview
12.9.3 Women’s Health Therapeutics Introduction
12.9.4 Eli Lilly and Company Revenue in Women’s Health Therapeutics Business (2014-2019)
12.9.5 Eli Lilly and Company Recent Development
12.10 GlaxoSmithKline plc
12.10.1 GlaxoSmithKline plc Company Details
12.10.2 Company Description and Business Overview
12.10.3 Women’s Health Therapeutics Introduction
12.10.4 GlaxoSmithKline plc Revenue in Women’s Health Therapeutics Business (2014-2019)
12.10.5 GlaxoSmithKline plc Recent Development
12.11 Mylan N.V.
12.12 Sanofi
12.13 Sun Pharmaceutical Industries Ltd.
12.14 CooperSurgical, Inc.
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Women’s Health Therapeutics Key Market Segments
Table Key Players Women’s Health Therapeutics Covered
Table Global Women’s Health Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Women’s Health Therapeutics Market Size Market Share by Type 2014-2025
Figure Infection Figures
Table Key Players of Infection
Figure Pregnancy Figures
Table Key Players of Pregnancy
Figure Oncology Figures
Table Key Players of Oncology
Table Global Women’s Health Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure <20 Years Old Case Studies
Figure 20~50 Years Old Case Studies
Figure >50 Years Old Case Studies
Figure Women’s Health Therapeutics Report Years Considered
Table Global Women’s Health Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Women’s Health Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Women’s Health Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Women’s Health Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Women’s Health Therapeutics Market Share by Regions 2014-2019
Figure Global Women’s Health Therapeutics Market Share by Regions 2014-2019
Figure Global Women’s Health Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Women’s Health Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Women’s Health Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Women’s Health Therapeutics Market Share by Manufacturers in 2018
Table Global Women’s Health Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Women’s Health Therapeutics Product/Solution/Service
Table Date of Enter into Women’s Health Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Women’s Health Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Women’s Health Therapeutics Market Size Share by Type (2014-2019)
Figure Global Women’s Health Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Women’s Health Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Women’s Health Therapeutics Market Size Share by Application (2014-2019)
Figure Global Women’s Health Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Women’s Health Therapeutics Revenue Market Share by Application in 2018
Figure United States Women’s Health Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Women’s Health Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Women’s Health Therapeutics Market Share (2018-2019)
Table United States Women’s Health Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Women’s Health Therapeutics Market Share by Type (2014-2019)
Table United States Women’s Health Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Women’s Health Therapeutics Market Share by Application (2014-2019)
Figure Europe Women’s Health Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Women’s Health Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Women’s Health Therapeutics Market Share (2018-2019)
Table Europe Women’s Health Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Women’s Health Therapeutics Market Share by Type (2014-2019)
Table Europe Women’s Health Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Women’s Health Therapeutics Market Share by Application (2014-2019)
Figure China Women’s Health Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Women’s Health Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Women’s Health Therapeutics Market Share (2018-2019)
Table China Women’s Health Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Women’s Health Therapeutics Market Share by Type (2014-2019)
Table China Women’s Health Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Women’s Health Therapeutics Market Share by Application (2014-2019)
Figure Japan Women’s Health Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Women’s Health Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Women’s Health Therapeutics Market Share (2018-2019)
Table Japan Women’s Health Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Women’s Health Therapeutics Market Share by Type (2014-2019)
Table Japan Women’s Health Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Women’s Health Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Women’s Health Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Women’s Health Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Women’s Health Therapeutics Market Share (2018-2019)
Table Southeast Asia Women’s Health Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Women’s Health Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Women’s Health Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Women’s Health Therapeutics Market Share by Application (2014-2019)
Figure India Women’s Health Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Women’s Health Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Women’s Health Therapeutics Market Share (2018-2019)
Table India Women’s Health Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Women’s Health Therapeutics Market Share by Type (2014-2019)
Table India Women’s Health Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Women’s Health Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Women’s Health Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Women’s Health Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Women’s Health Therapeutics Market Share (2018-2019)
Table Central & South America Women’s Health Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Women’s Health Therapeutics Market Share by Type (2014-2019)
Table Central & South America Women’s Health Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Women’s Health Therapeutics Market Share by Application (2014-2019)
Table Bayer AG Company Details
Table Bayer AG Revenue in Women’s Health Therapeutics Business (2014-2019) (Million US$)
Figure Bayer AG Revenue Growth Rate in Women’s Health Therapeutics Business (2014-2019)
Table Bayer AG Recent Development
Table Pfizer, Inc. Company Details
Table Pfizer, Inc. Revenue in Women’s Health Therapeutics Business (2014-2019)(Million US$)
Figure Pfizer, Inc. Revenue Growth Rate in Women’s Health Therapeutics Business (2014-2019)
Table Pfizer, Inc. Recent Development
Table Teva Pharmaceutical Company Details
Table Teva Pharmaceutical Revenue in Women’s Health Therapeutics Business (2014-2019)(Million US$)
Figure Teva Pharmaceutical Revenue Growth Rate in Women’s Health Therapeutics Business (2014-2019)
Table Teva Pharmaceutical Recent Development
Table F. Hoffmann-La Roche Ltd. Company Details
Table F. Hoffmann-La Roche Ltd. Revenue in Women’s Health Therapeutics Business (2014-2019)(Million US$)
Figure F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Women’s Health Therapeutics Business (2014-2019)
Table F. Hoffmann-La Roche Ltd. Recent Development
Table Merck & Co., Inc. Company Details
Table Merck & Co., Inc. Revenue in Women’s Health Therapeutics Business (2014-2019)(Million US$)
Figure Merck & Co., Inc. Revenue Growth Rate in Women’s Health Therapeutics Business (2014-2019)
Table Merck & Co., Inc. Recent Development
Table Bristol-Myers Squibb Company Company Details
Table Bristol-Myers Squibb Company Revenue in Women’s Health Therapeutics Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Company Revenue Growth Rate in Women’s Health Therapeutics Business (2014-2019)
Table Bristol-Myers Squibb Company Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Women’s Health Therapeutics Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Women’s Health Therapeutics Business (2014-2019)
Table AstraZeneca Recent Development
Table Novartis AG Company Details
Table Novartis AG Revenue in Women’s Health Therapeutics Business (2014-2019)(Million US$)
Figure Novartis AG Revenue Growth Rate in Women’s Health Therapeutics Business (2014-2019)
Table Novartis AG Recent Development
Table Eli Lilly and Company Company Details
Table Eli Lilly and Company Revenue in Women’s Health Therapeutics Business (2014-2019)(Million US$)
Figure Eli Lilly and Company Revenue Growth Rate in Women’s Health Therapeutics Business (2014-2019)
Table Eli Lilly and Company Recent Development
Table GlaxoSmithKline plc Company Details
Table GlaxoSmithKline plc Revenue in Women’s Health Therapeutics Business (2014-2019)(Million US$)
Figure GlaxoSmithKline plc Revenue Growth Rate in Women’s Health Therapeutics Business (2014-2019)
Table GlaxoSmithKline plc Recent Development
Table Mylan N.V. Company Details
Table Sanofi Company Details
Table Sun Pharmaceutical Industries Ltd. Company Details
Table CooperSurgical, Inc. Company Details
Table Global Women’s Health Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Women’s Health Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Women’s Health Therapeutics Market Size Share by Regions in 2025
Figure United States Women’s Health Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Women’s Health Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Women’s Health Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Women’s Health Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Women’s Health Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Women’s Health Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Women’s Health Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Women’s Health Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Women’s Health Therapeutics Market Size by Product (2019-2025)
Figure Global Women’s Health Therapeutics Market Size by Product in 2025
Table Global Women’s Health Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Women’s Health Therapeutics Market Size by Application (2019-2025)
Figure Global Women’s Health Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の女性の健康治療市場：市場規模・現状・予測 Women's experience of health and disease differ from those of men, due to unique biological, social and behavioural conditions. Biological differences vary all the way from phenotype to the cellular, and manifest unique risks for the development of ill health.Rise in cases of infertility and increas…- 世界の女性の健康診断市場：市場規模・現状・予測 Women's experience of health and disease differ from those of men, due to unique biological, social and behavioural conditions. Biological differences vary all the way from phenotype to the cellular, and manifest unique risks for the development of ill health.Rising prevalence of infectious diseases…
- 世界のデジタル治療薬＆ウェルネス市場：市場規模・現状・予測 Digital Therapeutics is an innovative new class of medicine that gives participants access to the world's most effective behavior therapies, enhanced with smart technology, and delivered directly to their fingerprints or front door.Digital therapeutics may be up and coming, but they also have a long…
- 世界の獣医感染症治療薬市場：市場規模・現状・予測 In 2018, the global Veterinary Infectious Disease Therapeutics market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025. This report focuses on the global Veterinary Infectious Disease Therapeutics status, future forecast, growth opportu…
- 世界の白斑治療学市場：市場規模・現状・予測 Vitiligo is a long-term skin condition characterized by patches of the skin losing their pigment. The patches of skin affected become white and usually have sharp margins. The hair from the skin may also become white.In 2018, the global Vitiligo Therapeutics market size was xx million US$ and it is …